Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Palisade Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Palisade Capital Management
from 13F filings
Historical chart of Palisade Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Palisade Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Palisade Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.5M | 1.1M | 1.41 |
| 2025-06-30 | $1.8M | 1.6M | 1.14 |
| 2025-03-31 | $2.0M | 1.6M | 1.28 |
| 2024-12-31 | $1.7M | 1.6M | 1.08 |
| 2024-09-30 | $1.3M | 1.1M | 1.19 |
| 2024-06-30 | $2.9M | 2.6M | 1.11 |
| 2024-03-31 | $3.5M | 3.6M | 0.97 |
| 2023-12-31 | $3.6M | 3.9M | 0.93 |
| 2023-09-30 | $3.6M | 3.9M | 0.93 |
More positions owned by Palisade Capital Management
View all positions for Palisade Capital Management
Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1
View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1